跳到正文
openFDA 已分级药品召回执法报告·· 26 天前精选AI 评分73

FDA 执法报告 D-0084-2027 将 Greenwich Rx 谷胱甘肽注射液微生物污染召回列为 I 类

FDA drug enforcement D-0084-2027: Greenwich Rx — Microbial Contamination of Sterile Products

AI 导读

FDA 执法报告 D-0084-2027 将 Greenwich Rx 的谷胱甘肽注射液召回列为 I 类,原因为无菌产品微生物污染。记录涉及 12 个批号、共 4,319 瓶 200 mg/mL、10 mL 多剂量瓶,仅限皮下注射,分销范围为全美,召回由企业自愿发起,召回启动日期为 2026-10-01。

推荐理由

记录列出 12 个批号及其 BUD 和全美销售范围,可核对该无菌注射剂召回的 I 类分级与批次边界。

正文 · AI 翻译

FDA 药品召回执法报告 — D-0084-2027

报告发布日期:2026-10-28。这是执法报告日期,不是召回启动日期。

范围:一条已分类的药品召回记录;event_id 可能归组多个产品。没有召回编号的未分类记录不在本数据流范围内。本记录不是新闻稿,也不是新的执法认定。

openFDA 数据集每周更新。报告状态不是实时召回状态,不得用于跟踪召回生命周期。以下其他日期保留其各自名称所对应的含义。

完整官方产品记录(包括 openFDA 统一标识符):

{

"address_1": "9733 Fm 2902 Rd. Suite 100",

"address_2": "",

"center_classification_date": "20261027",

"city": "Tomball",

"classification": "Class I",

"code_info": "Lot # 0060-062426-1, BUD: 10/02/2026; Lot # 0060-062726-1, BUD: 10/05/2026; Lot # 0060-070926-1, BUD: 10/17/2026; Lot # 0060-071426-1, BUD: 10/22/2026; Lot #0060-071426-2, BUD: 10/22/2026; Lot # 0060-072026-1, BUD: 10/28/2026; Lot # 0060-072726-1, BUD: 11/04/2026; Lot #0060-072926-1, BUD: 11/06/2026; Lot # 0060-073126-1; BUD: 11/08/2026; Lot # 0060-080426-1, BUD: 11/12/2026; Lot #: 0060-080526-1, BUD: 11/13/2026; Lot # 0060-081826-1, BUD: 11/26/2026.",

"country": "United States",

"distribution_pattern": "US Nationwide in th USA",

"event_id": "100004",

"initial_firm_notification": "Press Release",

"more_code_info": "",

"openfda": {},

"postal_code": "77375",

"product_description": "Glutathione Injection (Glutathione-L, Ascorbic Acid, Sodium Hydroxide, Bacteriostatic Water), 200 mg/mL, 10 mL multi-dose vial, Rx only, Subcutaneous Only, Greenwich Rx.",

"product_quantity": "4,319 vials",

"product_type": "Drugs",

"reason_for_recall": "Microbial Contamination of Sterile Products",

"recall_initiation_date": "20261001",

"recall_number": "D-0084-2027",

"recalling_firm": "Greenwich Rx",

"report_date": "20261028",

"state": "TX",

"status": "Ongoing",

"voluntary_mandated": "Voluntary: Firm initiated"

}

来源:openFDA 已分级药品召回执法报告 · api.fda.gov